Swiss biotech Bioversys AG shares started trading at 36.5 Swiss francs ($40.29) on the SIX Swiss Exchange on Friday, slightly up from the final price for its initial public offering (IPO) of 36 Swiss ...
A longstanding Sinophobia in the U.S. goes back to the 19th century, with the Chinese Exclusion Act, the tax on Chinese miners during the Gold Rush, and ...
Kong stocks strutted into their strongest weekly performance in four months, while the yen flexed its muscles on rising rate hike bets, and Amazon’s cloud dreams turned a bit stormy.